美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
65649-103-01	65649-103	HUMAN PRESCRIPTION DRUG	APRISO	mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20081031	N/A	NDA	NDA022301	Salix Pharmaceuticals, Inc.	MESALAMINE	375 mg/1	1 BOTTLE in 1 CARTON (65649-103-01) / 4 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
65649-103-02	65649-103	HUMAN PRESCRIPTION DRUG	APRISO	mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20081031	N/A	NDA	NDA022301	Salix Pharmaceuticals, Inc.	MESALAMINE	375 mg/1	1 BOTTLE in 1 CARTON (65649-103-02) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
0093-9224-89	0093-9224	HUMAN PRESCRIPTION DRUG	mesalamine	mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20210105	N/A	NDA AUTHORIZED GENERIC	NDA022301	Teva Pharmaceuticals USA, Inc.	MESALAMINE	375 mg/1	120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-9224-89)
70748-214-16	70748-214	HUMAN PRESCRIPTION DRUG	mesalamine	mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20200518	20250831	NDA AUTHORIZED GENERIC	NDA022301	Lupin Pharmaceuticals, Inc.	MESALAMINE	375 mg/1	120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70748-214-16)
68682-113-20	68682-113	HUMAN PRESCRIPTION DRUG	mesalamine	mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20180719	N/A	NDA AUTHORIZED GENERIC	NDA022301	Oceanside Pharmaceuticals	MESALAMINE	375 mg/1	1 BOTTLE in 1 CARTON (68682-113-20) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
43353-884-79	43353-884	HUMAN PRESCRIPTION DRUG	APRISO	mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20140217	N/A	NDA	NDA022301	Aphena Pharma Solutions - Tennessee, LLC	MESALAMINE	375 mg/1	2160 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43353-884-79)
63629-8827-1	63629-8827	HUMAN PRESCRIPTION DRUG	mesalamine	mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20210910	N/A	NDA AUTHORIZED GENERIC	NDA022301	Bryant Ranch Prepack	MESALAMINE	375 mg/1	120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63629-8827-1)